Picture of Johnson & Johnson logo

JNJ WD Johnson & Johnson Cashflow Statement

0.000.00%
us flag iconLast trade - 00:00
HealthcareHighly SpeculativeLarge CapNeutral

Annual cashflow statement for Johnson & Johnson, fiscal year end - January 1st, USD millions except per share, conversion factor applied.

2018
December 30th
2019
December 29th
2021
January 3rd
2022
January 2nd
2023
January 1st
Period Length:12 M12 M12 M12 M12 M
Source:10-K10-K10-K10-K10-K
Standards:
USG
USG
USG
USG
USG
Status:FinalFinalFinalFinalFinal
Net Income/Starting Line15,29715,11914,71420,87817,941
Depreciation
Deferred Taxes
Non-Cash Items988-101421,4591,957
Unusual Items
Other Non-Cash Items
Changes in Working Capital33,8652,690-4,238-4,011
Change in Accounts Receivable
Change in Inventories
Change in Other Assets
Change in Payable / Accrued Expenses
Change in Other Liabilities
Cash from Operating Activities22,20123,41623,53623,41021,194
Capital Expenditures-3,670-3,498-3,347-3,652-4,009
Purchase of Fixed Assets
Other Investing Cash Flow Items503-2,696-17,478-5,031-8,362
Acquisition of Business
Sale of Fixed Assets
Sale/Maturity of Investment
Change in Net Investments
Purchase of Investments
Other Investing Cash Flow
Cash from Investing Activities-3,167-6,194-20,825-8,683-12,371
Financing Cash Flow Items-148575-62739565
Other Financing Cash Flow
Total Cash Dividends Paid
Net Issuance / Retirement of Stock
Net Issuance / Retirement of Debt
Cash from Financing Activities-18,510-18,015-6,120-14,047-8,871
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash283-802-3,320502-360